Head and neck fibromato sis is a rare disease with a variable clinical picture. We report the case ofa 40-yearold woman who had a I-w eek history of a painl ess mass overlying her right neck. Histology conf irmed a diagnosis ofextra-abdominalfibromatosis. Two unusualfeatures of this case were the site of the lesion and its rapid growth. In this article, we discuss the clinical picture of head and neckfibromatosis, its etiology and pathology, and current opinion regarding its treatment. c p r o g r a m Yo u can earn 36 hours of category I Continuing Medical Ed ucation (CME) credits each year, simply by s uccessfu lly complet-
Introduction
Fibromatosis (desmoid tumor) was first described in 1832 by McFarlane. I The term desmoid, which was coined in 1838 by MUller, derives from the Greek desmos, which means band or ligament and is used to indicate an aponeurosis. ' Desmoid tumors are nonmetasta sizing soft-tissue masses that biologically fall between benign fibromas and malignant fibrosarcomas. Desmoid tumors can be divided into three subgroups: extra-abdominal, abdominal, and intraabdominal. The natural progression of desmoid tumors occurs slowly, and locally invasive growth leads to the compromise of local structures. ' Desmoid tumors are rare , accounting for only 0.03% of all neopl asms and 3% of all soft-tissue tumors. ' Extra-abdominal desmoid tumors are even less common.
In this article, we report a case of extra-abdominal fibromatosi s that was unusual not only in terms of its site, but also becau se of its rapid growth. 
Case report
A 40-year-old woman came to us with a l-week history of a right neck mass. The mass had increa sed rapidly in size over this period and was associated with intermittent pain in the right anterior aspect of her face and neck . The patient' s medical history included a C4-C7 vertebral fusion 2 years earlier and removal of a displaced bone graft 5 month s later. Clinical examination revealed a tender, solitary 4 x 3em mass in the right anterior triangle (level II) with extension over the sternocleidomastoid muscle. The mass was hard in consistency, had a smooth surface, and was immobile. Computed tomography (CT) of the neck detected a mass of uniform density that extended from the level of the hyoid bone to the lower aspect of the thyroid gland (figure 1). Ultrasound-guided Tru-Cut needle biopsy was performed, and histology identified dense connective tissue that contained strands of collagen mixed with plump fibrobl asts with prominent nucleoli. The tissue was whorled in appearance around thin-walled blood vessels . There was no notable inflammation or obviou s mitotic activity.
The patient was admitted to the hospital, and she underwent a complete macroscopic excision. Surgical exploration revealed an extensive 8 x 6-cm lesion in the right neck , deep to the sternocleidomastoid muscle and abutting the internal jugular vein, common carotid artery , and submandibular gland. The mass was hard in consistency and tethered to the carotid sheath with obliteration of fascial planes. A safe macroscopic exci sion was performed without sacrificing the neurovascular structures. Sectioning of the specimen revealed homogeneous, glistening , pale pink-white tissue with a rim of fatty tissue in places .
Histologically, the appearance of the specimen was similar to that of the Tru-Cut needle biopsy specimen; it was characterized by bundles of spindle cells and collagen and featured only a focal storiform pattern. The cell s were relatively small with tiny nucleoli , but no eel- 
Discussion
Extra-abdominal tumors. Extra-abd ominal fibro matosis tend s to occ ur as a solitary, painl ess, deep , firm , poorl y circumscribed tumo r that develops over a period of week s to months. Pain is rare unless there is ner ve invol vem ent. Indeed , other sy mpto ms arise only when local struc tures are in vol ved. Wh en nerves are involved, the patient might experience pai n, anes thes ia, paresthesia, hyperesth esia, and weakness. Involvement of the local mu scul ature ca n res ult in a loss of limb function.' Th e most co mmo n sites of extra-abdo minal tu mors are the pelvic and sho ulder girdles and prox ima l extre mities (50% of all cases), the trunk (43 %), and the he ad and neck reg ion (7%).4
Abdominaltumors. Abdominal-wall fibromatosis typically occ urs during or foll owing pregnancy .Th ese tum ors ca n be discovered as an incide nta l finding or they can be identi fied du ring an inves tiga tio n of pain or a growth.
Intra-abdominal tumors. Intra-abdomin al fibro matosis can remain silen t or it ca n appear in association with a fis tula, abdo minal pain, small-bowel obstruction, ureteric obstruction , and, in rare cases, bowel perforati on .' The incid ence of these tum ors is higher in childre n old er than 6 years and in young adults.I Th e incidence is also higher among fem ales, who are affected at an earlier age than are 
. A : Low-power view shows the interlacing bundles of spindle cells separated by variable amounts of collagen. B: High-power view shows the bland spindle cells with vesicular nuclei and small nucleoli interspersed with collagen.
males; fe ma les are also more likely than males to have multiple tum ors.v" Morbidi ty and mortality are associated wit h the lesion ' s local effects and wi th other diseases.
Etiology. Th e etiology of desmoid tu mors is not clearly defin ed , but there are a numb er of suspected associations:
Trauma and surge/yo Surgical scars and laparoscopi c port sites have been reported as sites of tum or growth, as have irradi ated areas and sites of spec ific injury.1.5-9
Pregnan cy and oral contraceptives. Hormonal factors are linked to abdominal-wa ll desm oid tum ors. Th ere are also rep orts of spontaneo us regression of tum ors follo wing oophorec to my or menopause.v" !'
Gardner 's syndro me. Intra-abd ominal desmoid tumors are often associate d with Gardn er' s syndro me, which is an autosomal co nditio n that is charac terize d by polyp osis coli, osteomas, cutaneo us or follic ular cysts, and fibromas.P?
Genetic mutations. No definit e ge ne tic link to desmoid tumors has been found , but there has been a report of an Volume 82, Number 4 extr a-abdominal desmoid tumor arising in a patien t with muscular dy strophy of the limb girdle (Chr I mutation)." There have also been reports of tumors in severa l members of one family ." :"
Histopathology. Histopathologically, desm oid tumors can be confused with low-grade malignanc ies (e.g ., a grade I fibro sarcom a). Othe r disea se pro cesses to be considered in the differenti al diagno sis include nodul ar fasciitis and reactive fibrobl astic proliferation . Although desmoid tumo rs are histologically ben ign , mole cular studies have shown them to be neopl astic , and they do not represent a response to inten se inflammation. Their neoplastic nature ha s been confirmed by a demonstration that these tumo rs are the result of monoclonal processes that often involve chromosom al aberrations and by a find ing that their proliferation might be driv en by a decreased express ion of the retinoblastom a gen e." Microscopically , desmoid tumors app ear as poorly circums cribed ma sses of fibrou s tissu e that contain myofibroblasts and fibroblasts surrounded by collagen. Numerous spindle cells are apparent, and stromal blood vessels are narrow and slit-like. Mitoses are few in number, and nuclei are elongated and usually vesicular with multiple small nucleoli. The cell cytoplasm is elongated and tapered .v' Expression of estrogen receptors has been reported, but this has not been wid ely demonstrated.1,7 Immunohistochemical stains for vimentin, alpha smoothmuscle actin, and mu scle actin are often positive,17 and the pre sence of proli ferating cell nucl ear anti gen has been documented .'
Management. Managing desmoid tumors has proved to be challenging bec ause of the difficulty in assessing the true extent of the tumors, both clinically and histologically, along with the high recurrenc e rate follo win g intervention. Surgery is the first-line tre atment, with or without adj uvant radiation therapy , 8, 18, 19 Wide exci sion al margins encompass ing normal tissue are de sired to minimize the possibility of nonpalpable extensions alon g mu scle bundles and fasci al plan es.v" ? Despite wide margins , reports of recurrence in 25 to 86 % of patients have been documentedv":"; patients with extra-abdominal tumors, especially on the extremit ies, are at high er risk.' It is still unclear .whether the positivity or negativity of resection margin s is useful in predi ctin g loc al recurrence rates .' Magnetic reson ance imaging might be useful in delineating the tumor outline for resection. Such delin eation might lead to a reduction in the risk of recurrence, wh ich was reported in one study to ran ge from 39 to 48 %.1 Reports of ben efit from radiotherap y have been variable. Result s ha ve ran ged from no decrease in loc al recurrence rates v" to good long-term control rates as high as 76 % . 6, 19, 20, 29 Howeve r, radiother apy is belie ved to be of value (1) as an adj unct to surge ry when only conservative 324 exc ision is possibl e or (2) as a primary treatment when a tumor is unre sectable.!" Radi othe rapy can significantly reduce the volume of viable tumor prior to surgery, and it can decrease the need for mor e radical interventions such as amputation.v" The ben efit s of high-dose radi ation should be balanc ed with its potential side effects, which include postirradiation fibrosis , joint contractures, neurop athy , radiation-induced sarcoma, and disturbance of phy seal growth plates in younger patients. 1 Other treatm ent options are still in ex perimental stages, and only small numbers have been reported thu s far. Trials of chemotherapeutic agents are in their early phases, and no benefit has yet been shown. One of the limitations of chemotherapy is that desmoid tumors grow so slow1Y.1,5 Non steroid al anti-inflammatory drug s have been proposed as a treatment option, but results are conflicting.1,5 Som e reports of endocrine treatments-including antiestrogen s and progestational agents-have been promising. In one study, the overall respon se to tamoxifen was 51 %, despit e the fa ct tha t most desmoid tumors lack estro gen receptors.'
